Tag: Gisela Mautner

Noxopharm doses first patient in NOXCOVID-1 clinical trial with Veyonda

pharmanewsdaily- October 9, 2020

Australian drug development company Noxopharm has dosed the first patient in the phase 1 NOXCOVID-1 clinical trial with Veyonda, its lead pipeline candidate, in hospitalized ... Read More